E. Garry Menzel

Insider Reports History

Entity
Individual
Location
C/O Regulus Therapeutics Inc., 3545 John Hopkins Court Suite 210, San Diego, CA
Signature
/s/ Garry Menzel
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by E. Garry Menzel:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Adaptimmune Therapeutics PLC Director American Depositary Shares representing Ordinary Shares 75.1K $50.5K $0.67 Jul 10, 2023 Direct
Adaptimmune Therapeutics PLC Director Option to purchase Ordinary Shares 1.12M Jul 1, 2024 Direct
Black Diamond Therapeutics, Inc. Director Stock Option (Right to Buy) 30.6K Jun 6, 2024 Direct
Stoke Therapeutics, Inc. Director Director Stock Option (Right to Buy) 7.64K Jun 5, 2024 Direct
TCR2 THERAPEUTICS INC. President and CEO, Director Common Stock 0 $1.72 Jun 1, 2023 Direct
TCR2 THERAPEUTICS INC. President and CEO, Director Common Stock 0 $1.72 Jun 1, 2023 Indirect
TCR2 THERAPEUTICS INC. President and CEO, Director Restricted Stock Unit 0 Jun 1, 2023 Direct
TCR2 THERAPEUTICS INC. President and CEO, Director Stock Option (Right to Buy) 0 $0.74 Jun 1, 2023 Direct

Insider Reports Filed by E. Garry Menzel

Symbol Company Period Transactions Value $ Form Type Date Filed Role
ADAP Adaptimmune Therapeutics PLC Jul 1, 2024 1 $0 4 Jul 1, 2024 Director
BDTX Black Diamond Therapeutics, Inc. Jun 6, 2024 1 $0 4 Jun 6, 2024 Director
STOK Stoke Therapeutics, Inc. Jun 5, 2024 1 $0 4 Jun 7, 2024 Director
ADAP Adaptimmune Therapeutics PLC Jul 10, 2023 1 -$43.4K 4 Jul 10, 2023 Director
ADAP Adaptimmune Therapeutics PLC Jul 5, 2023 7 $0 4 Jul 5, 2023 Director
ADAP Adaptimmune Therapeutics PLC Jul 3, 2023 1 $0 4 Jul 3, 2023 Director
STOK Stoke Therapeutics, Inc. Jun 13, 2023 1 $0 4 Jun 15, 2023 Director
ADAP Adaptimmune Therapeutics PLC Jun 1, 2023 3 $0 4 Jun 1, 2023 Director
ADAP Adaptimmune Therapeutics PLC Jun 1, 2023 0 $0 3 Jun 1, 2023 Director
TCRR TCR2 THERAPEUTICS INC. Jun 1, 2023 11 $0 4 Jun 1, 2023 President and CEO, Director
BDTX Black Diamond Therapeutics, Inc. May 16, 2023 1 $0 4 May 17, 2023 Director
TCRR TCR2 THERAPEUTICS INC. Dec 15, 2022 2 $0 4 Dec 19, 2022 President and CEO, Director
TCRR TCR2 THERAPEUTICS INC. Dec 9, 2022 3 -$35K 4 Dec 13, 2022 President and CEO, Director
TCRR TCR2 THERAPEUTICS INC. Dec 7, 2022 2 -$23.4K 4 Dec 9, 2022 President and CEO, Director
TCRR TCR2 THERAPEUTICS INC. Dec 5, 2022 2 -$31.8K 4 Dec 7, 2022 President and CEO, Director
TCRR TCR2 THERAPEUTICS INC. Dec 1, 2022 5 -$11.7K 4 Dec 5, 2022 President & CEO, Director
TCRR TCR2 THERAPEUTICS INC. Nov 17, 2022 12 $0 4 Nov 18, 2022 President and CEO, Director
TCRR TCR2 THERAPEUTICS INC. Jul 5, 2022 6 $0 4 Aug 26, 2022 President & CEO, Director
BDTX Black Diamond Therapeutics, Inc. Jun 10, 2022 1 $0 4 Jun 13, 2022 Director
STOK Stoke Therapeutics, Inc. Jun 7, 2022 1 $0 4 Jun 8, 2022 Director
TCRR TCR2 THERAPEUTICS INC. Feb 28, 2022 1 $3.28K 4 Mar 18, 2022 President & CEO, Director
TCRR TCR2 THERAPEUTICS INC. Aug 31, 2021 5 $265K 4 Dec 10, 2021 President & CEO, Director
BDTX Black Diamond Therapeutics, Inc. Jun 18, 2021 1 $0 4 Jun 22, 2021 Director
STOK Stoke Therapeutics, Inc. Jun 8, 2021 1 $0 4 Jun 25, 2021 Director